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Objective(s): NOTCH signaling pathway is well known for its role in cell fate, cell survival, cell 
differentiation, and apoptosis. Some of the NOTCH signaling genes are critical for endometrial function 
and implantation in animals and appear to play a similar role in humans. The purpose of the current 
study was to investigate the potential roles of some main components of the NOTCH family in human 
endometrium during implantation period in common gynecological diseases.
Materials and Methods: Endometrial NOTCH receptors NOTCH1, 3, 4 and ligand JAG1, 2 and survivin 
mRNA expression were investigated using the Q-PCR technique and the amount of the JAG1, 2 proteins 
was also determined by Western blot. Samples were obtained from 12 patients with endometriosis, 
12 patients with repeated implantation failure (RIF), 12 patients with Polycystic Ovary Syndrome 
(PCOS) and 10 healthy fertile women as a control group. Data were analyzed using SPSS version 18. 
Group comparisons were performed by one-way ANOVA or Kruskal-Wallis.
Results: All patient groups failed to show the expected mid-luteal increase in NOTCH1, JAG 1, 2, and 
survivin expression as documented in the control group. Moreover, a significant rise in NOTCH3 
expression levels was found only in PCOS women. There was a direct correlation between gene 
expression and protein level for JAG 1, 2.
Conclusion: Aberrant NOTCH signaling molecules expression suggests that altered development of 
the endometrium at the molecular level may be associated with the impaired decidualization and 
implantation failure in gynecological disorders such as endometriosis, PCOS, and RIF.
Article history:
Received: Jun 25, 2018








►Please cite this article as:  
Amjadi F, Salehi E, Zandieh Z, Rashidi M, Taleahmad S, Javedani masrour M, Aflatoonian R, Mehdizadeh M. Comparative evaluation of NOTCH 
signaling molecules in the endometrium of women with various gynecological diseases during the window of implantation. Iran J Basic Med Sci 
2019; 22:426-431. doi: 10.22038/ijbms.2019.32961.7874
Introduction
Implantation is a key part of early pregnancy in 
which blastocyst adheres and penetrates into the wall 
of the receptive endometrium. A complex sequence of 
cellular and molecular changes should take place at the 
maternal endometrium in order to permit the embryo to 
invade the decidua (1). Until recently, the exact factors 
mediating the endometrial receptivity were not fully 
understood. Among these, NOTCH signaling genes are 
supposed to be important factors in the endometrial 
function (2).
NOTCH signaling is an evolutionarily conserved 
pathway, which regulates cell proliferation, cell fate 
determination, cell invasion, differentiation, and 
apoptosis (3, 4). Each of these processes absolutely 
exhibits an important role in endometrial remodeling. In 
mammals, NOTCH signaling family includes four NOTCH 
receptors (NOTCH1-4), five ligands, three Delta-like 
proteins (DLL1,3,4) and two Jagged proteins (JAG1,2). 
Both the NOTCH receptors and ligands are single-pass 
transmembrane proteins, hence, NOTCH signaling is 
activated upon cell-to-cell contact (5). Receptor/ligand 
interaction at the cell surface, activates proteolytic 
cleavage of the receptor, leading to the release of 
intracellular NOTCH receptor domain, which enters 
the cell nucleus and induces the NOTCH target genes 
expression (6, 7), including survivin (8).
There are only a few reports concerning the 
expression pattern and role of the NOTCH pathway in 
the human endometrium. In physiological conditions, 
significant increase in endometrial NOTCH1 and 
decrease in NOTCH4 during the luteal phase, suggests 
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that NOTCH-4 likely contributes more to the controlling 
proliferation, while, NOTCH-1 more likely involves 
in the differentiation programming (2). In addition, 
an up-regulated expression of JAG1 and DLL4 as the 
NOTCH ligands localized in the endometrium have been 
reported during the mid-luteal phase, which implies 
their involvement in the endometrial receptivity(9).
It has been shown that endometrial remodeling, 
decidualization and embryo implantation could be 
modulated by the NOTCH signaling in mice. Afshar et. al. 
indicated a decrease in proliferation and up-regulation 
of apoptosis-associated genes via inhibition of NOTCH1 
signaling during decidualization (10). PCOS (40%), 
endometriosis (50%), repeated implantation failure 
(10%) are three common causes of female infertility 
(11-13).
Women with PCOS, endometriosis, and RIF have been 
reported to exhibit an altered expression pattern of 
receptivity markers during the period of implantation 
(14-17). Therefore, the aim of this study was to evaluate 
the expression of the NOTCH receptors (NOTCH1, 
NOTCH2, NOTCH3), ligands (JAG1and JAG2) and target 
gene, and survivin, in the endometrium of patients with 
PCOS, endometriosis, repeated implantation failure 
(RIF) and healthy fertile women during the window of 
implantation.
Materials and Methods
Patients and tissue selection 
This prospective study was performed, during a 
12 months’ period from September 2015 to October 
2016. Signed informed consent was taken from each 
participant and the study was approved by the local 
Ethics Committee at Iran University of Medical Sciences 
(IUMS, no 19950). Human endometrial tissue samples 
were obtained from PCOS women (n=12), endometriosis 
(n=12), RIF patients (n=12), and healthy fertile women 
in the secretory phase (on days 3–5 after ovulation, 
n=10). Patients with chronic oligo/anovulation (cycle 
length >35 days and < 6 months), hyperandrogenism, 
and polycystic ovaries were identified as PCOS 
(consistent with Rotterdam criteria). The timing of 
the LH surge, ultrasound scanning, and histological 
evaluation, confirmed that samples were harvested 
during the luteal phase. The mean age of the subjects was 
26 years (range: 18–35). Women with any pathological 
uterine disorder and endometrial hyperplasia were not 
included. They also had not used hormonal medications 
or an intrauterine contraceptive device in the previous 
three months. Under sterile conditions, endometrial 
biopsies were collected using Pipelle catheters (Pipelle, 
Laboratoire CCD, France). Each endometrial sample was 
cut into two portions: for RNA and protein extraction, 
the first part was put inside a Cryo tube containing 1 ml 
RNA later (Ambion, Austin, TX, USA). Another part was 
fixed in formalin to perform histological dating.
RNA extraction, cDNA synthesis, and reverse 
transcription polymerase chain reaction (RT-PCR)
Total RNA was isolated from endometrial tissue 
samples by homogenization in Trizol reagent (Sigma 
Pool, UK), following the manufacturer’s instructions. 
To remove genomic DNA contamination, RNA samples 
were purified with DNase I (Fermentas, Sankt Leon-
Rot, Germany). RNA was reverse transcribed into cDNA 
using SuperScript First-Strand Synthesis System (200 
U/μl, fermentase). Negative controls were prepared as 
non-reverse transcribed controls (RT controls). The RT-
PCR was done using prepared cDNA, Platinum Blue PCR 
SuperMix (Invitrogen, Paisley, Scotland, UK), and the 
forward and reverse primers for NOTCH1-3, JAG1, JAG2 
and survivin (Metabion, Martinsried, Bavaria, Germany). 
The used primer sequences are described in Table 1. The 
RT-PCR conditions for 40 cycles were as follows: 95 °C for 
30 sec, 60 °C for 1 min, and 72 °C for 1 min. To separate 
PCR products, agarose gel (1.2%) electrophoresis and 
visualizing via an ultraviolet transillumination were 
carried out. The identity of the amplified product was 
confirmed by the sequencing of the RT-PCR products. 
β-actin was considered as a reference gene (18).
Quantitative real-time polymerase chain reaction 
(qPCR) 
All transcripts were quantified in triplicates using an 
ABI Prism 7300 apparatus (Applied Biosystems, Foster 
City, California, USA). The total reaction volume was 20 







Gene symbol Forward  primer Reversed primer 
β-actin TGACCCAGATCATGTTTGAGACC GGAGGAGCAATGATCTTGATCTTC 
NOTCH1 AGAAGATGCTCCAGCAACACA GCAAGTCTCCTACAAAACACGG 
NOTCH2 AATGAGTGTCTGAGTGAACCCT GACTCCATCAAATCCTGCCTG 
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μl containing 250 ng cDNA, 5 pmol of each primer, and 
SYBR Green reagent (Applied Biosystems) with ROX dye 
as a passive control for signal intensity. Amplification 
was carried out at 95 °C for 30 sec, 60 °C for 30 sec, and 
72 °C for 30 sec. Melting curves of PCR reactions were 
used to check the formation of nonspecific products and 
primer-dimer. The efficiency of the primers was tested 
by the standard curves.
To analysis qPCR results, the comparative CT method 
was utilized. ΔCT was defined as the difference between 
the number of cycles required for amplification of the 
candidate gene and the human β-actin (reference gene 
selected). Then, ΔΔCT was calculated as the difference 
between the groups and 2-ΔΔCT was reported as mRNA 
fold change (FC) (18).
Western blotting 
A 50 µg protein aliquot from each sample was 
separated on SDS-polyacrylamide gel and then blotted 
onto polyvinylidene fluoride (PVDF) membranes (Bio-
Rad, USA). The membranes were blocked with 5% BSA 
and 0.1% Tween-20 (Sigma-Aldrich, St. Louis, MO, USA). 
Then, the membranes were incubated with the primary 
anti-JAG1 antibody (1:100; Abcam ab7771, Cambridge, 
UK), anti-JAG2 antibody (1:100; Abcam ab109627, 
Cambridge, UK) and β-actin (1:200; Sigma-Aldrich, 
St. Louis, MO, USA) overnight at 4 °C. The blots were 
then washed with TBST, incubated with horseradish 
peroxidase (HRP)-conjugated secondary antibody 
(1:200; Abcam, ab7086) for 1 hr at room temperature. 
After washing with TBST, immunodetection was achieved 
with the chemiluminescent peroxidase substrate (ECL 
Advance, GE Healthcare, UK) and blots were exposed 
to x-ray films (GE, 28906835). Consequently, the films 
were scanned with a densitometer (GS-800, Bio-Rad, 
USA). The signal intensity of JAG1 and JAG2 relative to 
the density of β-actin band was computed using the 
Image G software. As a negative control, the blots were 
treated with non-immunized serum as the primary 
antibody.
Statistical analysis
Data were analyzed using SPSS version 18 and are 
described as mean ± SD. Distribution of data was checked 
with the Kolmogorov-Smirnov test. Between groups 
comparisons were performed by one-way ANOVA for 
the data with normal distribution and by the Kruskal-
Wallis for non-parametric data. Statistical significance 
was set at P<0.05.
Results
Expression of NOTCH receptors in the endometrium 
of women with gynecological diseases compared with 
the healthy fertile women
qPCR analysis indicated a significant decrease in 
NOTCH1 mRNA expression levels of women with PCOS, 
endometriosis and RIF groups compared with the 
healthy group during the implantation window (Figure 
1). As shown in Figure 2, mRNA expression of NOTCH2 
has no statistically significant difference between the 
women with different gynecological diseases and the 




































Figure 1. Gene expression pattern of NOTCH receptors (NOTCH1, NOTCH2, NOTCH3) in women with polycystic ovary syndrome(PCOS), 
endometriosis, and repeated implantation failure(RIF) groups compared with the control group (mean± SEM)
** represents significance at P<0.01, *** represents significance at P<0.001
****represents significance at P<0.0001
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significantly up-regulated only in the PCOS group 
compared with the healthy fertile women (Figure 3).
Expression of NOTCH ligands in the endometrium of 
women with gynecological diseases compared with 
the healthy fertile women
A significantly lower expression of JAG1 was observed 
in PCOS (P<0.0001), endometriosis (P<0.001), and RIF 
(P<0.001) groups compared with the healthy fertile 
women (Figure 2, a). Furthermore, JAG2 gene expression 
was significantly down-regulated in the endometrium 
of PCOS (P<0.0001), endometriosis (P<0.05), and RIF 
(P<0.0001) groups compared with control subjects 
(Figure 2, b). 
Expression of the NOTCH target gene, survivin, in the 
endometrium of women with gynecological diseases 
compared with the healthy fertile women
As shown in Figure 3, survivin gene expression was 
decreased in the endometrial samples of PCOS women, 
and endometriosis and RIF groups compared with 
healthy women.
Immunoblotting analysis of NOTCH ligands in the 
endometrium of women with gynecological diseases 
compared with the healthy fertile women
Western blot analysis showed a significantly lower 
JAG1 and JAG2 protein expression in the endometrial 
samples of PCOS patients, and endometriosis and RIF 
groups compared with the healthy fertile ones (Figure 4). 
Discussion
In the current study, the expression pattern of 
NOTCH signaling molecules as potential biomarkers 
was assessed in the endometrial samples taken during 
the mid-luteal phase of women with endometriosis, 
PCOS, and RIF. Our results showed that NOTCH pathway 
molecules including NOTCH1, 3, JAG1, 2, and survivin are 
differently expressed in the patient groups compared 
with healthy controls. A large body of evidence suggests 
that aberrant endometrial receptivity may attribute 
to the undesired reproductive outcomes in common 
gynecological disorders including PCOS, endometriosis, 
and RIF (19-22). Various biological molecules have 
been proposed to contribute to the impairment of 
decidualization and endometrial receptivity (23). 
NOTCH pathway mediates cell differentiation, cell 
progression, and cell death and regulates angiogenesis 
(24-26). All of these processes are critical for 
successful implantation (1, 27). Su et. al. indicated that 
endometrial NOTCH molecules attenuate in patients 
with endometriosis. They suggested that the decreased 
NOTCH signaling contributes to the decidualization 
defects and therefore insufficient uterine receptivity 
(28).
Inconsistently, the current study demonstrated 
that NOTCH1, JAG-1, JAG-2, and survivin, as a down 
target molecule of NOTCH pathway, significantly 
decrease in women with PCOS, endometriosis, and 
RIF. It is documented that NOTCH1 is involved in 
decidual angiogenesis and endometrial differentiation, 
while NOTCH3 and 4 control the proliferation (2, 29). 
Animal studies have shown that NOTCH1 silencing 
leads to the decrease in IL-11 and IGFBP1 as two main 
Figure 2. Gene expression pattern of NOTCH ligands (JAG1, JAG2) in women with polycystic ovary syndrome (PCOS), endometriosis, and repeated 
implantation failure (RIF) groups compared with the control group (mean± SEM)
* represents significance at P<0.05, *** represents significance at P<0.001 























Figure 3. Gene expression pattern of NOTCH target gene survivin in 
women with polycystic ovary syndrome (PCOS), endometriosis and 
repeated implantation failure (RIF) groups compared with the control 
group (mean±SEM)
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human decidualization biomarkers (10). Moreover, 
NOTCH1 deficiency results in the reduction of bone 
morphogenetic protein2 (bmp2) and wnt4 in the mouse 
uterus, which are necessary for the decidualization (10). 
A recent study has revealed that NOTCH1 and NOTCH 
ligands including JAG1 and DLL1 are down-regulated in 
the endometrium of women with unexplained infertility 
during the implantation window compared with the 
fertile subjects (30). DLL1 changes integrin α6 and 
integrin β1 expression, which have essential roles in the 
embryo implantation (31). The expression of JAG1 was 
increased from proliferative into secretory phase, which 
proposes a responsibility for JAG1 in the endometrial 
receptivity (2, 30), and the endometrial expression 
of JAG2 was decreased in endometriosis, which is 
contributed to the decidualization failure (28).
Interestingly, we found NOTCH-3 increased in PCOS 
exclusively. Previous studies revealed that the NOTCH 
system plays a pivotal role in maintaining balance 
between cell proliferation and cell death (32). It has 
been shown that NOTCH3 increases endometrial cell 
proliferation, and NOTCH1 promotes differentiation (2, 
29). It seems both underexpression of NOTCH1, as well 
as overexpression of NOTCH3, may have detrimental 
effects on uterine receptivity in PCOS patients. Also, 
increased NOTCH3 expression may be related to the 
elevated endometrial thickness and hyperplasia that is 
seen in women with PCOS.
Conclusion
In summary, our findings illustrate that dysregulated 
NOTCH signaling molecules during the window of 
implantation may be associated with implantation 
problems and consequently poor outcomes observed in 
endometriosis, PCOS, and RIF. However, our knowledge 
is still limited due to the complexity of this pathway. 
Hence, much remains to be discovered about the role 
of the NOTCH signaling pathway and its changes during 
the mid-luteal phase in normal and disease conditions.
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